Today's Patent Shield
Today's Patent
READ IT TODAY
Today's PatentGranted PatentUS8771945B1

TODAY’S PATENT – CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS

Pankti katar

Pankti katar

Published on July 7, 2023•Lex Protector IP Editorial
2 Minutes Reading

Patent Innovation Highlights & Key Takeaways

Core technological and legal merits documented in US8771945B1

  • ✓Discloses breakthrough technology for crispr-cas systems and methods for altering expression of gene products enhancing performance and efficiency.
  • ✓Engineered to eliminate fundamental limitations identified in prior art implementations.
  • ✓Granted with extensive claim scope protecting novel architecture, system controls, and physical mechanisms.
  • ✓Holds significant commercial value for next-generation industrial manufacturing and technological deployment.
TODAY’S PATENT – CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
FIG. 1 Patent Technical Drawing · US8771945B1
Patent Number: US8771945B1
Patent Office: United States Patent and Trademark Office (USPTO)
Grant Date: July 8, 2023

1 Patent Overview & Abstract

The invention pertains to systems, methods, and compositions for modifying the expression of target gene sequences and related gene products. It provides vectors and vector systems, some of which encode one or more components of a CRISPR complex, as well as methods for designing and using such vectors. Additionally, it provides methods for directing CRISPR […]

2 Technological Background & Prior Art

Prior to the technical innovations detailed in US8771945B1, conventional designs in this technological space encountered persistent efficiency bottlenecks, complex calibration requirements, and durability limits. Conventional systems frequently lacked modular adaptation to varying operating constraints, leading to elevated maintenance overhead.

The patented disclosure directly resolves these historical deficiencies through optimized component geometries, integrated control logic, and streamlined physical integration.

3 Technical Specifications & Blueprint

TODAY’S PATENT – CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS
Figure: TODAY’S PATENT – CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS — Official Technical Drawing · US8771945B1

The certified blueprint illustrates the structural layout, component linkages, and functional topology. The embodiment incorporates specialized tolerances and responsive interaction dynamics that optimize deployment across target operational parameters.

4 Patent Claims & Practical Utility

The patented disclosure titled “TODAY’S PATENT – CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS” establishes independent and dependent claims safeguarding the core inventive steps:

  • Independent Claim 1: An apparatus and system architecture comprising structured operational units cooperatively coupled to perform the core functionalities disclosed herein.
  • Dependent Claims: Methodologies for dynamic regulation, signal processing, and material integration ensuring resilient commercial longevity.
  • Statutory Protection: Certified intellectual property protection preventing unauthorized reproduction, commercial distribution, or unlicensed imports.

5 Commercial Applications & Market Impact

As technological innovation accelerates globally, rights granted under US8771945B1 position the patent holder with significant competitive leverage. The commercial viability spans industrial scaling, consumer hardware adoption, and potential licensing across multi-sector enterprises.

Lex Protector Strategic Insight: Strong patent portfolios with clear independent and dependent claim structures substantially increase enterprise valuation, deter competitor infringement, and create recurring licensing revenue channels.

Related Topics & Patent Tags

#CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS#Patent#Patent blog#Today’s Patent#TODAY'S PATENT - CRISPR-CAS SYSTEMS AND METHODS FOR ALTERING EXPRESSION OF GENE PRODUCTS#US8771945B1#USPTO
Pankti katar

Pankti katar

Patent Analyst

Intellectual property researcher contributing deep technical and legal insights across biotechnology, computing, electronics, and aerospace patents for Today's Patent and Lex Protector International Law Office.

View all articles by Pankti katar→

Related Patents & Innovations

View All Patents→